Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2008

View Archived Issues

Hydrogen peroxide scavenging prolongs life span in experimental Friedreich's ataxia

Targeting specific GABA-A receptor subunits shows potential in treating chronic pain

Preliminary safety and tolerability data reported from phase I MRX-4 study

Nymox to report results of new phase II study of NX-1207 in BPH

FDA grants authorization to Arpida for phase II trial of iclaprim in cSSSI

BioInvent receives Danish approval to initiate phase I clinical trial of BI-204

Medicure announces second quarter fiscal 2008 results

FDA places clinical hold on YM BioSciences' phase II AP5 study of AeroLEF for pain

Cogentus initiates CG106 clinical study to examine antiplatelet activity of CGT-2168

Karo Bio reports positive results from phase IIb study of eprotirome

Flanders government awards grant to Galapagos for RA drug development

Henderson Morley and the ACVD enter agreement for cytomegalovirus vaccine

QLT restructures company and puts Eligard, Aczone and Atrigel up for sale

Roche extends tender offer for Ventana until March 2008

Boehringer completes enrollment in RE-LY trial of Pradaxa for atrial fibrillation

Regeneration and Tutogen change name to RTI Biologics following merger

FDA grants SPA approval to Agennix for phase III trial of talactoferrin alfa for NSCLC

GM-CSF disclosed as target of MorphoSys' MOR-103 program for RA

Synvista and Novel Therapeutic Technologies enter agreement for ALT-2074 for psoriasis

FDA approves single tablet combination of Tekturna and diuretic in hypertension

FDA approves Abbott's Humira for moderate to severe chronic plaque psoriasis

FDA grants Intelence accelerated approval for HIV combination therapy

FDA approves Welchol for glucose reduction in adults with type 2 diabetes

Novel treatments for musculoskeletal and connective tissue disorders described in patent literature

Recent Sia Peptides patent discloses new stress-relieving agents

Recent patents disclose novel antiinfective agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...